- Calcineurin Inhibitor Induced Multiple Infarctions
-
Jeong HB, Kim JM, Yu IH, Bae JH, Kwon OS, Park KY
- KMID: 2364940
- J Korean Soc Transplant.
- 2016 Dec;30(4):190-193.
- doi: 10.4285/jkstn.2016.30.4.190
Tacrolimus is the most commonly used immunosuppressant after kidney transplantation. Here, we report a patient with multiple cerebral infarctions during tacrolimus treatment after kidney transplantation. A 54-year-old female was admitted... -
- CITED
-
- Close
- SHARE
-
- Close
- A Successful Case of a High Anti A/B Antibody Titer ABO Incompatible Kidney Transplantation Patient Who Received a Kidney from a Hepatitis B Carrier
-
Lee JH, Kim HS, Lee DY, Oh JS, Sin YH, Kim JK, Park JH, Huh K, Park JI
- KMID: 2364939
- J Korean Soc Transplant.
- 2016 Dec;30(4):184-189.
- doi: 10.4285/jkstn.2016.30.4.184
Kidney transplantation (KTP) lowers the mortality and morbidity of patients with end-stage renal disease. Post-transplantation infection and antibody mediated rejection (AMR) are the most common complications. Hepatitis B surface antigen... -
- CITED
-
- Close
- SHARE
-
- Close
- Hand-assisted Laparoscopic Donor Surgery for Living Donor Pancreas and Kidney Transplantation: A Single Center Experience
-
Kim JS, Jung CW, Jun H, Park KT
- KMID: 2364938
- J Korean Soc Transplant.
- 2016 Dec;30(4):178-183.
- doi: 10.4285/jkstn.2016.30.4.178
BACKGROUND: In this era of donor shortage, use of organs from living donors has increased significantly. Nonetheless, less than 1% of pancreas transplantations involve living donors, despite the immunological benefits,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Bile Duct Probe for Bile Duct Division during Donor Right Hemihepatectomy
-
Bae SJ, Han DH, Choi GH, Choi JS
- KMID: 2364937
- J Korean Soc Transplant.
- 2016 Dec;30(4):172-177.
- doi: 10.4285/jkstn.2016.30.4.172
BACKGROUND: To prevent bile duct related complications, exact division of donor bile duct is essential, not only for the recipient, but also for the donor during living donor liver transplantation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Sirolimus Combination with Tacrolimus in Kidney Transplant Recipients at High Immunological Risk: Observational Results 3 Years after Transplantation
-
Lee J, Song SH, Lee JG, Kim BS, Huh KH, Kim YS
- KMID: 2364936
- J Korean Soc Transplant.
- 2016 Dec;30(4):165-171.
- doi: 10.4285/jkstn.2016.30.4.165
BACKGROUND: The optimal immunosuppressive strategy for renal transplant recipients at high immunological risk requires clarification. We compared the 3 year outcomes of a sirolimus group (tacrolimus plus sirolimus) to those... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes for Patients with Hepatitis C Virus after Liver Transplantation in Korea
-
Kim JM
- KMID: 2364935
- J Korean Soc Transplant.
- 2016 Dec;30(4):155-164.
- doi: 10.4285/jkstn.2016.30.4.155
Hepatitis C virus (HCV)-related liver disease is the most common indication for liver transplantation (LT) in Western countries, whereas HCV LT is rare in Korea. We conducted a survey of... -
- CITED
-
- Close
- SHARE
-
- Close
- Strategy for Hepatitis C Treatment in Liver Transplant Settings
-
Park JY
- KMID: 2364934
- J Korean Soc Transplant.
- 2016 Dec;30(4):149-154.
- doi: 10.4285/jkstn.2016.30.4.149
In patients with detectable virus at the time of liver transplantation, hepatitis C virus (HCV) infection always recurs on the graft, and 30% of patients have an aggressive clinical and... -
- CITED
-
- Close
- SHARE
-
- Close
